Rohan Palekar - Apr 1, 2024 Form 4 Insider Report for 89bio, Inc. (ETNB)

Signature
/s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
Stock symbol
ETNB
Transactions as of
Apr 1, 2024
Transactions value $
-$526,903
Form type
4
Date filed
4/3/2024, 04:01 PM
Previous filing
Feb 28, 2024
Next filing
Jun 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Options Exercise $48.3K +25K +5.13% $1.93* 512K Apr 1, 2024 Direct
transaction ETNB Common Stock Sale -$575K -52.7K -10.3% $10.91 459K Apr 1, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Options Exercise $0 -25K -17.21% $0.00 120K Apr 1, 2024 Common Stock 25K $1.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on July 5, 2023.
F2 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.65 to $11.54. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F3 This option is vested in full.